PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
PT Kalbe Farma EPS Diluted (Quarterly) : 0.0011 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0011 |
| March 31, 2026 | 0.0013 |
| December 31, 2025 | 0.0014 |
| September 30, 2025 | 0.0009 |
| June 30, 2025 | 0.0012 |
| March 31, 2025 | 0.0014 |
| December 31, 2024 | 0.0012 |
| September 30, 2024 | 0.0008 |
| June 30, 2024 | 0.0011 |
| March 31, 2024 | 0.0013 |
| December 31, 2023 | 0.001 |
| September 30, 2023 | 0.0008 |
| June 30, 2023 | 0.001 |
| March 31, 2023 | 0.0012 |
| December 31, 2022 | 0.0012 |
| September 30, 2022 | 0.0012 |
| June 30, 2022 | 0.0012 |
| March 31, 2022 | 0.0012 |
| December 31, 2021 | 0.0013 |
| September 30, 2021 | 0.0012 |
| June 30, 2021 | 0.0012 |
| March 31, 2021 | 0.0011 |
| December 31, 2020 | 0.001 |
| September 30, 2020 | 0.0009 |
| June 30, 2020 | 0.001 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.001 |
| December 31, 2019 | 0.0009 |
| September 30, 2019 | 0.001 |
| June 30, 2019 | 0.001 |
| March 31, 2019 | 0.0009 |
| December 31, 2018 | 0.0009 |
| September 30, 2018 | 0.0009 |
| June 30, 2018 | 0.001 |
| March 31, 2018 | 0.0009 |
| December 31, 2017 | 0.001 |
| September 30, 2017 | 0.0009 |
| June 30, 2017 | 0.001 |
| March 31, 2017 | 0.0009 |
| December 31, 2016 | 0.001 |
| September 30, 2016 | 0.0009 |
| June 30, 2016 | 0.0009 |
| March 31, 2016 | 0.0009 |
| December 31, 2015 | 0.0008 |
| September 30, 2015 | 0.0006 |
| June 30, 2015 | 0.0008 |
| March 31, 2015 | 0.0009 |
| December 31, 2014 | 0.001 |
| September 30, 2014 | 0.0009 |
| June 30, 2014 | 0.0009 |
| March 31, 2014 | 0.0009 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Avadel Pharmaceuticals Plc | 0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.51M |
| Revenue (Quarterly) | 559.49M |
| Total Expenses (Quarterly) | 508.65M |
| Enterprise Value | 2.219B |
| Gross Profit Margin (Quarterly) | 35.90% |
| Profit Margin (Quarterly) | 9.39% |
| Earnings Yield | 8.97% |
| Operating Earnings Yield | 11.45% |
| Normalized Earnings Yield | 8.970 |